Arboretum
New approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.
Sectors
Healthtech + ServicesLife Sciences
Status
PrivateLocation
Cambridge, MAInitial Investment
2024
New approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.
A next-generation molecular information company with a mission to make precision medicine a reality for some of the most common diseases that impact patients around the world. Founded by leaders in data science from the Broad Institute, Arboretum’s approach integrates AI and genetic testing to expand access to genomic medicine for patients and enable recruitment of genomically profiled patients for clinical research partners.